TABLE 6.
Relevant biosafety and biosecurity documents applicable for gene editing technologies adapted from the World Health Organization (WHO) and the Centers for Disease Control and Prevention (CDC), US.
| Guidance titles | Year published |
| World Health Organization (WHO)a | |
| Guidance on regulations for the transport of infectious substances 2019–2020 | 2019 |
| Biosafety video series | 2019 |
| WHO Global Consultative Meeting on the Safe Shipment of Infectious Substances: 15–16 March 2018 | 2018 |
| WHO consultative meeting high/maximum containment (biosafety level 4) laboratories networking: 13-15 December 2017 | 2018 |
| Report of an extended meeting of the biosafety advisory group: 13–15 December 2016 | 2018 |
| Extended Biosafety Advisory Group meeting, 24–26 November 2014 | 2015 |
| Laboratory Biorisk Management: Strategic Framework for Action 2012–2016 | 2012 |
| Responsible life sciences research for global health security | 2010 |
| Biorisk management: Laboratory biosecurity guidance | 2006 |
| Public health response to biological and chemical weapons: WHO guidance | 2004 |
| Laboratory biosafety manual: 3rd Edition | 2004 |
| Centers for Disease Control and Prevention (CDC), USb | |
| Biosafety in Microbiological and Biomedical Laboratories (BMBL) 5th Edition | 2009 |
aAdapted from WHO Biorisk management: core documents: https://www.who.int/ihr/publications/bioriskmanagement_1/en/.
bAdapted from CDC Biosafety in Microbiological and Biomedical Laboratories (BMBL) 5th Edition: https://www.cdc.gov/labs/BMBL.html.